Clinical data | |
---|---|
Trade names | Metopirone |
AHFS/Drugs.com | Consumer Drug Information |
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 1.9 ± 0.7 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.188 |
Chemical and physical data | |
Formula | C14H14N2O |
Molar mass | 226.279 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Metyrapone, sold under the brand name Metopirone, is a medication which is used in the diagnosis of adrenal insufficiency and occasionally in the treatment of Cushing's syndrome (hypercortisolism). It is part of the steroidogenesis inhibitor class of drugs.